{"id":"https://openalex.org/W51984850","doi":null,"title":"Development of 64Cu- and 68Ga-somatostatin receptor antagonists for improved PET imaging","display_name":"Development of 64Cu- and 68Ga-somatostatin receptor antagonists for improved PET imaging","publication_year":2011,"publication_date":"2011-05-01","ids":{"openalex":"https://openalex.org/W51984850","mag":"51984850"},"language":"en","primary_location":{"id":"mag:51984850","doi":null,"is_oa":false,"landing_page_url":"https://jnm.snmjournals.org/content/52/supplement_1/1491","pdf_url":null,"source":{"id":"https://openalex.org/S4210180780","display_name":"Journal of Nuclear Medicine","issn_l":"0161-5505","issn":["0161-5505","1535-5667","2159-662X"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":["dongbi-a","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315767","host_organization_name":"Society of Nuclear Medicine and Molecular Imaging","host_organization_lineage":["https://openalex.org/P4310315767"],"host_organization_lineage_names":["Society of Nuclear Medicine and Molecular Imaging"],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"Journal of Nuclear Medicine","raw_type":null},"volume":null,"type":"article","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5050675255","display_name":"Melpomeni Fani","orcid":"https://orcid.org/0000-0002-9309-1604","observed_orcids":["https://orcid.org/0000-0002-9309-1604"]},"institutions":[{"id":"https://openalex.org/I2801240073","display_name":"University Medical Center Freiburg","ror":"https://ror.org/03vzbgh69","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I2801240073"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Melpomeni Fani","raw_affiliation_strings":["Univ Hospital Freiburg, Freiburg, Germany"],"raw_orcid":"https://orcid.org/0000-0002-9309-1604","affiliations":[{"raw_affiliation_string":"Univ Hospital Freiburg, Freiburg, Germany","institution_ids":["https://openalex.org/I2801240073"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5076884072","display_name":"Luigi Del Pozzo","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2801240073","display_name":"University Medical Center Freiburg","ror":"https://ror.org/03vzbgh69","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I2801240073"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Luigi Del Pozzo","raw_affiliation_strings":["Univ Hospital Freiburg, Freiburg, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Univ Hospital Freiburg, Freiburg, Germany","institution_ids":["https://openalex.org/I2801240073"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5081937224","display_name":"K. Abiraj","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2802542264","display_name":"University Hospital of Basel","ror":"https://ror.org/04k51q396","country_code":"CH","type":"healthcare","lineage":["https://openalex.org/I2802542264"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"K. Abiraj","raw_affiliation_strings":["University Hospital Basel , Basel , Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University Hospital Basel , Basel , Switzerland","institution_ids":["https://openalex.org/I2802542264"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058629794","display_name":"Rosalba Mansi","orcid":"https://orcid.org/0000-0003-0342-8865","observed_orcids":["https://orcid.org/0000-0003-0342-8865"]},"institutions":[{"id":"https://openalex.org/I2801240073","display_name":"University Medical Center Freiburg","ror":"https://ror.org/03vzbgh69","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I2801240073"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Rosalba Mansi","raw_affiliation_strings":["Univ Hospital Freiburg, Freiburg, Germany"],"raw_orcid":"https://orcid.org/0000-0003-0342-8865","affiliations":[{"raw_affiliation_string":"Univ Hospital Freiburg, Freiburg, Germany","institution_ids":["https://openalex.org/I2801240073"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054379533","display_name":"Maria Luisa Tamma","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2802542264","display_name":"University Hospital of Basel","ror":"https://ror.org/04k51q396","country_code":"CH","type":"healthcare","lineage":["https://openalex.org/I2802542264"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Maria Luisa Tamma","raw_affiliation_strings":["University Hospital Basel , Basel , Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University Hospital Basel , Basel , Switzerland","institution_ids":["https://openalex.org/I2802542264"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035742901","display_name":"Renzo Cescato","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I118564535","display_name":"University of Bern","ror":"https://ror.org/02k7v4d05","country_code":"CH","type":"education","lineage":["https://openalex.org/I118564535"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Renzo Cescato","raw_affiliation_strings":["Univ Bern, Bern, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Univ Bern, Bern, Switzerland","institution_ids":["https://openalex.org/I118564535"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061906450","display_name":"Beatrice Waser","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I118564535","display_name":"University of Bern","ror":"https://ror.org/02k7v4d05","country_code":"CH","type":"education","lineage":["https://openalex.org/I118564535"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Beatrice Waser","raw_affiliation_strings":["Univ Bern, Bern, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Univ Bern, Bern, Switzerland","institution_ids":["https://openalex.org/I118564535"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080877411","display_name":"Wolfgang Weber","orcid":"https://orcid.org/0000-0002-7854-4345","observed_orcids":["https://orcid.org/0000-0002-7854-4345"]},"institutions":[{"id":"https://openalex.org/I2801240073","display_name":"University Medical Center Freiburg","ror":"https://ror.org/03vzbgh69","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I2801240073"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Wolfgang Weber","raw_affiliation_strings":["Univ Hospital Freiburg, Freiburg, Germany"],"raw_orcid":"https://orcid.org/0000-0002-7854-4345","affiliations":[{"raw_affiliation_string":"Univ Hospital Freiburg, Freiburg, Germany","institution_ids":["https://openalex.org/I2801240073"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108321253","display_name":"Jean Claude Reubi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I118564535","display_name":"University of Bern","ror":"https://ror.org/02k7v4d05","country_code":"CH","type":"education","lineage":["https://openalex.org/I118564535"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Jean Claude Reubi","raw_affiliation_strings":["Univ Bern, Bern, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Univ Bern, Bern, Switzerland","institution_ids":["https://openalex.org/I118564535"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5013094846","display_name":"Helmut R. Ma\u00ebcke","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2801240073","display_name":"University Medical Center Freiburg","ror":"https://ror.org/03vzbgh69","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I2801240073"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Helmut R. Ma\u00ebcke","raw_affiliation_strings":["Univ Hospital Freiburg, Freiburg, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Univ Hospital Freiburg, Freiburg, Germany","institution_ids":["https://openalex.org/I2801240073"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.00669625,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"52","issue":null,"first_page":"1491","last_page":"1491"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11395","display_name":"Radiopharmaceutical Chemistry and Applications","score":0.5464000105857849,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11395","display_name":"Radiopharmaceutical Chemistry and Applications","score":0.5464000105857849,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10754","display_name":"Neuroendocrine Tumor Research Advances","score":0.44850000739097595,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10522","display_name":"Medical Imaging Techniques and Applications","score":0.0015999999595806003,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/somatostatin-receptor-antagonists","display_name":"somatostatin receptor antagonists","score":0.9779999852180481},{"id":"https://openalex.org/keywords/neuroendocrine-tumors","display_name":"neuroendocrine tumors","score":0.8479999899864197},{"id":"https://openalex.org/keywords/nodaga","display_name":"NODAGA","score":0.7829999923706055},{"id":"https://openalex.org/keywords/dota","display_name":"DOTA","score":0.7620000243186951},{"id":"https://openalex.org/keywords/macrocyclic-chelators","display_name":"macrocyclic chelators","score":0.9449999928474426},{"id":"https://openalex.org/keywords/receptor-binding-affinity","display_name":"receptor binding affinity","score":0.6349999904632568},{"id":"https://openalex.org/keywords/tumor-uptake","display_name":"tumor uptake","score":0.5630000233650208},{"id":"https://openalex.org/keywords/tissue-distribution","display_name":"tissue distribution","score":0.9340000152587891},{"id":"https://openalex.org/keywords/tumor-to-background-ratio","display_name":"tumor-to-background ratio","score":0.7160000205039978},{"id":"https://openalex.org/keywords/positron-emission-tomography","display_name":"positron emission tomography","score":0.4350000023841858},{"id":"https://openalex.org/keywords/radionuclide-therapy","display_name":"radionuclide therapy","score":0.8500000238418579}],"concepts":[{"id":"https://openalex.org/C2777807558","wikidata":"https://www.wikidata.org/wiki/Q4914764","display_name":"Biodistribution","level":3,"score":0.8976569771766663},{"id":"https://openalex.org/C80115893","wikidata":"https://www.wikidata.org/wiki/Q2067077","display_name":"Somatostatin receptor","level":3,"score":0.7165325284004211},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.6550468802452087},{"id":"https://openalex.org/C2776885963","wikidata":"https://www.wikidata.org/wiki/Q245204","display_name":"Antagonist","level":3,"score":0.5279597043991089},{"id":"https://openalex.org/C2776297358","wikidata":"https://www.wikidata.org/wiki/Q407166","display_name":"Somatostatin","level":2,"score":0.507900059223175},{"id":"https://openalex.org/C2779931791","wikidata":"https://www.wikidata.org/wiki/Q161515","display_name":"DOTA","level":3,"score":0.4959789216518402},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4793756306171417},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.4671351909637451},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.42786988615989685},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.23346206545829773},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.22766360640525818},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.1879260540008545},{"id":"https://openalex.org/C197404232","wikidata":"https://www.wikidata.org/wiki/Q319827","display_name":"Chelation","level":2,"score":0.17104360461235046},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.13589859008789062},{"id":"https://openalex.org/C178790620","wikidata":"https://www.wikidata.org/wiki/Q11351","display_name":"Organic chemistry","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"mag:51984850","doi":null,"is_oa":false,"landing_page_url":"https://jnm.snmjournals.org/content/52/supplement_1/1491","pdf_url":null,"source":{"id":"https://openalex.org/S4210180780","display_name":"Journal of Nuclear Medicine","issn_l":"0161-5505","issn":["0161-5505","1535-5667","2159-662X"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":["dongbi-a","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315767","host_organization_name":"Society of Nuclear Medicine and Molecular Imaging","host_organization_lineage":["https://openalex.org/P4310315767"],"host_organization_lineage_names":["Society of Nuclear Medicine and Molecular Imaging"],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"Journal of Nuclear Medicine","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9476000070571899,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2049089156","https://openalex.org/W2801417462","https://openalex.org/W2005389389","https://openalex.org/W2167919948","https://openalex.org/W2018848884","https://openalex.org/W2099879304","https://openalex.org/W2907295900","https://openalex.org/W4403337716","https://openalex.org/W2057064048","https://openalex.org/W6942405140"],"abstract_inverted_index":{"1491":[0],"Objectives":[2],"Targeting":[4],"of":[5,14,24,53,164,240],"somatostatin":[6],"receptor":[7,94],"(sst)-positive":[8],"tumors":[9],"with":[10,82,93,119,123],"radiolabeled":[11],"agonists":[12,36],"is":[13],"high":[15,156,227],"clinical":[16,260],"interest":[17],"in":[18],"targeted":[19],"imaging":[20,220,264],"and":[21,42,51,56,78,80,84,88,96,103,110,113,139,141,157,172,184,203,207,213,225,238,242],"radionuclide":[22],"therapy":[23],"neuroendocrine":[25],"tumors.":[26],"Recently,":[27],"we":[28],"showed":[29],"that":[30],"antagonists":[31,244],"may":[32],"be":[33],"preferable":[34],"to":[35,72],"as":[37,262],"they":[38],"exhibited":[39],"better":[40],"pharmacokinetics":[41,239],"higher":[43,194],"tumor":[44,159,174,223],"uptake.":[45],"Our":[46],"report":[47],"describes":[48],"the":[49,146,173,248,256],"development":[50],"evaluation":[52],"four":[54,252],"64Cu-":[55,241],"68Ga-PET":[57],"tracers":[58],"based":[59],"on":[60,137],"a":[61],"novel":[62],"antagonist.":[63],"Methods":[65],"The":[67,152,236],"antagonist":[68],"LM3":[69],"was":[70,170],"conjugated":[71],"three":[73],"macrocyclic":[74],"chelators,":[75],"CB-TE2A,":[76],"NODAGA":[77],"DOTA":[79],"labeled":[81],"64Cu":[83],"68Ga.":[85],"Binding":[86],"affinity":[87,237],"antagonistic":[89,132],"properties":[90],"were":[91,117,192],"determined":[92],"autoradiography":[95],"immunofluorescence":[97],"microscopy":[98],"using":[99],"HEK-sst2":[100,120],"cells.":[101],"Biodistribution":[102],"microPET":[104],"studies":[105,154],"for":[106,178,187,195,198,214,217,231,259],"64Cu-CB-TE2A/NODAGA-LM3":[107],"(1,":[108],"4":[109],"24h":[111,182,211],"p.i.)":[112,116,183,212],"68Ga-NODAGA/DOTA-LM3":[114],"(1h":[115],"performed":[118],"xenografts,":[121],"along":[122],"blocking":[124],"experiments.":[125],"Results":[127],"All":[129],"metalloconjugates":[130],"demonstrated":[131],"properties.":[133],"Their":[134],"affinities":[135],"depend":[136],"chelator":[138],"(radio)metal":[140],"vary":[142],"~10-fold;":[143],"Ga-NODAGA-LM3":[144],"having":[145],"lowest":[147],"IC50":[148],"value":[149],"(1.3\u00b10.3":[150],"nmol/L).":[151],"biodistribution":[153],"show":[155],"specific":[158],"uptake":[160],"1h":[161],"p.i.,":[162],"particularly":[163],"64Cu-/68Ga-NODAGA-LM3":[165,254],"(~":[166,180],"40%ID/g).":[167],"Background":[168],"clearance":[169],"fast":[171],"washout":[175],"relatively":[176],"slow":[177],"64Cu-NODAGA-LM3":[179,196],"15%ID/g,":[181],"almost":[185],"negligible":[186],"64Cu-CB-TE2A-LM3.":[188],"Tumor-to-normal":[189],"tissue":[190],"ratios":[191],"significantly":[193],"than":[197,216],"64Cu-CB-TE2A-LM3":[199],"(e.g.":[200],"tumor-to-kidney:":[201],"12.8\u00b13.6":[202],"1.7\u00b10.3,":[204],"tumor-to-muscles:":[205],"1342\u00b1115":[206],"75.2\u00b18.5,":[208],"respectively,":[209],"at":[210],"68Ga-NODAGA-LM3":[215],"68Ga-DOTA-LM3.":[218],"MicroPET":[219],"shows":[221],"clear":[222],"localisation":[224],"very":[226],"image":[228],"contrast,":[229],"especially":[230],"64Cu-/68Ga-NODAGA-LM3.":[232],"Conclusions":[234],"68Ga-somatostatin":[243],"are":[245,255],"influenced":[246],"by":[247],"chelate.":[249],"Among":[250],"all":[251],"radioconjugates":[253],"best":[257],"candidates":[258],"translation":[261],"PET":[263],"probes":[265]},"counts_by_year":[],"updated_date":"2026-07-07T06:19:30.733796","created_date":"2016-06-24T00:00:00"}